MedPath

Assessment of the effects of smaller drops versus regular sized drops of topical anaesthetic drops

Phase 4
Conditions
Health Condition 1: H539- Unspecified visual disturbance
Registration Number
CTRI/2024/08/072298
Lead Sponsor
anodropper, Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients = 18 years

2) Ability to provide informed consent for mode of topical anesthesia delivery

3) Ability to verbally respond to pain

4) Receiving treatment at AEH OPD (patient has undergone a preliminary examination and is awaiting dilation)

Exclusion Criteria

1)Have a contraindication to local anaesthetics.

2)Intravitreal injection within the past 14 days.

3)Recent ocular surgery within the past 4 weeks.

4)Preexisting diagnosis of ocular surface disease. requiring punctal plug placement.

5)Evidence of any current ocular inflammation/infection.

6)Any previous ocular condition (i.e., neurotrophic keratitis, herpetic eye disease, presence of a corneal graft, etc.) that has permanently altered the native sensation of the ocular surface.

7)Use of contact lenses.

8)Use of exclusionary medications:

9)Topical steroid drops, NSAIDS, IOP lowering eye drops, any anti-viral medications used for herpes, Opioids

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The results of this study might implicate the nanodropper as a viable and desirable solution to oversized drop-induced waste.Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
It may further support the revision of existing institutional policies to allow for extended use of multi-dose bottles <br/ ><br>Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath